Dr. Dinender Singla and Chakri Toleti (IMAGE)
Caption
To help accelerate the path to manufacturing the therapy for clinical use and advancing into FDA clinical trials for heart disease and cancer treatment, Dinender Singla (right) partnered with Orlando investor and UCF donor Chakri Toleti, a healthcare technology entrepreneur.
Credit
UCF College of Medicine
Usage Restrictions
For use with coverage with UCF's exosome research. Credit must be given to the University of Central Florida.
License
Original content